1 paper
Technical University of Munich
1 trialPhase 4254 people
1 trialPhase 460 people
Ukrainian Medical Stomatological Academy
1 trialPhase 443 people
Minneapolis Heart Institute Foundation
1 trialPhase 425 people
1 trialPhase 298 people
National Institute on Minority Health and Health DisparitiesUS$433.3k
Mean Fatigue Severity Scale scores were 0.43 points lower than placebo at day 60 and 0.58 points lower at day 90.Mean Fatigue Severity Scale scores were 0.43 points lower than placebo at day 60 and 0.58 points lower at day 90.
The compound reduced perineuronal nets, dampened glial activation, and cut immune cell infiltration while restoring recognition memory.The compound reduced perineuronal nets, dampened glial activation, and cut immune cell infiltration while restoring recognition memory.